维基百科

LL-100

LL-100是100种人类淋巴瘤（Lymphoma）与白血病（Leukemia）细胞系的列表[1]，用于药物筛选等许多生物医学研究[2]。

细胞系

编辑

Pre-B-ALL

编辑
细胞系 性别 年龄 文献 外部链接
697 男 12Y [3] CVCL_0079 （页面存档备份，存于互联网档案馆）
KOPN-8 女 3M [4] CVCL_1866 （页面存档备份，存于互联网档案馆）
NALM-6 男 19Y [5] CVCL_0092 （页面存档备份，存于互联网档案馆）
REH 女 15Y [6] CVCL_1650 （页面存档备份，存于互联网档案馆）
SEM 女 5Y [7] CVCL_0095 （页面存档备份，存于互联网档案馆）

B-NHL：伯基特淋巴瘤/B-ALL

编辑
细胞系 性别 年龄 文献 外部链接
BJAB 女 5Y [8] CVCL_5711 （页面存档备份，存于互联网档案馆）
Daudi 男 16Y [9] CVCL_0008 （页面存档备份，存于互联网档案馆）
Raji 男 11Y [10] CVCL_0511 （页面存档备份，存于互联网档案馆）
Ramos 男 3Y [11] CVCL_0597 （页面存档备份，存于互联网档案馆）
VAL 女 50Y [12] CVCL_1819 （页面存档备份，存于互联网档案馆）

B-NHL: 慢性淋巴细胞白血病/PLL

编辑
细胞系 性别 年龄 文献 外部链接
HG-3 男 70Y [13] CVCL_Y547 （页面存档备份，存于互联网档案馆）
JVM-3 男 73Y [14] CVCL_1320 （页面存档备份，存于互联网档案馆）
JVM-13 男 60-69Y [15] CVCL_1318 （页面存档备份，存于互联网档案馆）
MEC-1 男 61Y [16] CVCL_1870 （页面存档备份，存于互联网档案馆）
PGA-1 男 未知 [17] CVCL_Y545 （页面存档备份，存于互联网档案馆）

B-NHL: DLBCL ABC

编辑
细胞系 性别 年龄 文献 外部链接
NU-DHL-1 男 73Y [18] CVCL_1876 （页面存档备份，存于互联网档案馆）
OCI-Ly3 男 52Y [19] CVCL_8800 （页面存档备份，存于互联网档案馆）
Ri-1 女 57Y [20] CVCL_1885 （页面存档备份，存于互联网档案馆）
U-2932 女 29Y [21] CVCL_1896 （页面存档备份，存于互联网档案馆）
U-2946 男 52Y [22] CVCL_X503[失效链接]

B-NHL: DLBCL GC

编辑
Cell line 性别 年龄 文献 外部链接
DoHH2 男 60Y [23] CVCL_1179 （页面存档备份，存于互联网档案馆）
OCI-Ly7 男 48Y [19] CVCL_1881[失效链接]
OCI-Ly19 女 27Y [24] CVCL_1878 （页面存档备份，存于互联网档案馆）
SU-DHL-4 男 38Y [25] CVCL_0539 （页面存档备份，存于互联网档案馆）
SU-DHL-6 男 43Y [25] CVCL_2206 （页面存档备份，存于互联网档案馆）
WSU-DLCL2 男 41Y [26] CVCL_1902 （页面存档备份，存于互联网档案馆）

B-NHL: 毛细胞白血病

编辑
细胞系 性别 年龄 文献 外部链接
BONNA-12 男 46Y [27] CVCL_1090 （页面存档备份，存于互联网档案馆）
Hair-M 男 86Y [28] CVCL_B401 （页面存档备份，存于互联网档案馆）
HC-1 男 56Y [29] CVCL_1243 （页面存档备份，存于互联网档案馆）

B-NHL: 被套细胞淋巴瘤

编辑
细胞系 性别 年龄 文献 外部链接
Granta-519 女 58Y [30] CVCL_1818 （页面存档备份，存于互联网档案馆）
JeKo-1 女 78Y [31] CVCL_1865 （页面存档备份，存于互联网档案馆）
JVM-2 女 63Y [14] CVCL_1319 （页面存档备份，存于互联网档案馆）
Mino 男 68Y [32] CVCL_1872 （页面存档备份，存于互联网档案馆）
REC-1 男 61Y [33] CVCL_1884 （页面存档备份，存于互联网档案馆）

B-NHL: PEL

编辑
细胞系 性别 年龄 文献 外部链接
BC-3 男 85Y [34] CVCL_1080 （页面存档备份，存于互联网档案馆）
BCBL-1 男 40Y [35] CVCL_0165 （页面存档备份，存于互联网档案馆）
CRO-AP2 男 49Y [36] CVCL_1147 （页面存档备份，存于互联网档案馆）
CRO-AP5 男 35Y [37] CVCL_1148 （页面存档备份，存于互联网档案馆）

B-NHL: PMBL

编辑
细胞系 性别 年龄 文献 外部链接
U-2940 女 18Y [38] CVCL_1897 （页面存档备份，存于互联网档案馆）

多发性骨髓瘤/PCL

编辑
细胞系 性别 年龄 文献 外部链接
KMS-12-BM 女 64Y [39] CVCL_1334 （页面存档备份，存于互联网档案馆）
L-363 女 36Y [40] CVCL_1357 （页面存档备份，存于互联网档案馆）
LP-1 女 56Y [41] CVCL_0012 （页面存档备份，存于互联网档案馆）
OPM-2 女 56Y [42] CVCL_1625 （页面存档备份，存于互联网档案馆）
RPMI-8226 男 61Y [43] CVCL_0014 （页面存档备份，存于互联网档案馆）
U-266 男 53Y [44] CVCL_0566 （页面存档备份，存于互联网档案馆）

霍奇金淋巴瘤

编辑
细胞系 性别 年龄 文献 外部链接
HDLM-2 男 74Y [45] CVCL_0009 （页面存档备份，存于互联网档案馆）
KM-H2 男 37Y [46] CVCL_1330 （页面存档备份，存于互联网档案馆）
L-428 女 37Y [45] CVCL_1361 （页面存档备份，存于互联网档案馆）
L-1236 男 34Y [47] CVCL_2096 （页面存档备份，存于互联网档案馆）
SUP-HD1 男 37Y [48] CVCL_2208 （页面存档备份，存于互联网档案馆）

T-ALL/T-LL

编辑
细胞系 性别 年龄 文献 外部链接
CCRF-CEM 女 3Y11M [49] CVCL_0207 （页面存档备份，存于互联网档案馆）
DND-41 男 13Y [50] CVCL_2022 （页面存档备份，存于互联网档案馆）
HPB-ALL 男 14Y [51] CVCL_1820 （页面存档备份，存于互联网档案馆）
Jurkat 男 14Y [52] CVCL_0065 （页面存档备份，存于互联网档案馆）
MOLT-4 男 19Y [53] CVCL_0013 （页面存档备份，存于互联网档案馆）
RPMI-8402 女 16Y [54] CVCL_1667 （页面存档备份，存于互联网档案馆）

Mature T-Malignancy

编辑
细胞系 性别 年龄 文献 外部链接
DERL-7 男 30Y [55] CVCL_2017 （页面存档备份，存于互联网档案馆）
HH 男 61Y [56] CVCL_1280 （页面存档备份，存于互联网档案馆）
MOTN-1 女 65Y [57] CVCL_2127 （页面存档备份，存于互联网档案馆）

NK Malignancy

编辑
细胞系 性别 年龄 文献 外部链接
KHYG-1 女 45Y [58] CVCL_2976 （页面存档备份，存于互联网档案馆）
NK-92 男 50Y [59] CVCL_2142 （页面存档备份，存于互联网档案馆）
YT 男 15Y [60] CVCL_1797 （页面存档备份，存于互联网档案馆）

间变性大细胞淋巴瘤

编辑
细胞系 性别 年龄 文献 外部链接
DEL 男 12Y [61] CVCL_1170 （页面存档备份，存于互联网档案馆）
SR-786 男 11Y [62] CVCL_1711 （页面存档备份，存于互联网档案馆）
SU-DHL-1 男 10Y [63] CVCL_0538 （页面存档备份，存于互联网档案馆）
SUP-M2 女 5Y [64] CVCL_2209 （页面存档备份，存于互联网档案馆）

AML myelocytic

编辑
细胞系 性别 年龄 文献 外部链接
EoL-1 男 33Y [65] CVCL_0258 （页面存档备份，存于互联网档案馆）
HL-60 女 36Y [66] CVCL_0002 （页面存档备份，存于互联网档案馆）
Kasumi-1 男 7Y [67] CVCL_0589 （页面存档备份，存于互联网档案馆）
KG-1 男 59Y [68] CVCL_0374 （页面存档备份，存于互联网档案馆）
NB4 女 23Y [69] CVCL_0005 （页面存档备份，存于互联网档案馆）
OCI-AML3 男 57Y [70] CVCL_1844 （页面存档备份，存于互联网档案馆）
SKNO-1 男 22Y [71] CVCL_2196 （页面存档备份，存于互联网档案馆）

AML monocytic

编辑
细胞系 性别 年龄 文献 外部链接
ME-1 男 40Y [72] CVCL_2110 （页面存档备份，存于互联网档案馆）
MOLM-13 男 20Y [73] CVCL_2119 （页面存档备份，存于互联网档案馆）
Mono-Mac-6 男 64Y [74] CVCL_1426 （页面存档备份，存于互联网档案馆）
MUTZ-3 男 29Y [75] CVCL_1433 （页面存档备份，存于互联网档案馆）
THP-1 男 1Y [76] CVCL_0006 （页面存档备份，存于互联网档案馆）
U-937 男 37Y [77] CVCL_0007 （页面存档备份，存于互联网档案馆）

AML erythroid

编辑
细胞系 性别 年龄 文献 外部链接
F-36P 男 68Y [78] CVCL_2037 （页面存档备份，存于互联网档案馆）
HEL 男 30Y [79] CVCL_0001 （页面存档备份，存于互联网档案馆）
OCI-M2 未知 56Y [80] CVCL_2150 （页面存档备份，存于互联网档案馆）
TF-1 男 35Y [81] CVCL_0559 （页面存档备份，存于互联网档案馆）

AML megakaryocytic

编辑
细胞系 性别 年龄 文献 外部链接
CMK 男 10M [82][83] CVCL_0216 （页面存档备份，存于互联网档案馆）
ELF-153 男 41Y [84] CVCL_2031 （页面存档备份，存于互联网档案馆）
M-07e 女 6M [85] CVCL_2106 （页面存档备份，存于互联网档案馆）
MEGAL 女 未知 [86] CVCL_1833 （页面存档备份，存于互联网档案馆）
MKPL-1 男 66Y [87] CVCL_2116 （页面存档备份，存于互联网档案馆）
UT-7 男 64Y [83] CVCL_2233 （页面存档备份，存于互联网档案馆）

CML myeloid BC

编辑
细胞系 性别 年龄 文献 外部链接
EM-2 女 5Y [88] CVCL_1196 （页面存档备份，存于互联网档案馆）
K-562 女 53Y [89][90] CVCL_0004 （页面存档备份，存于互联网档案馆）
KCL-22 女 32Y [91] CVCL_2091 （页面存档备份，存于互联网档案馆）
Ku812 男 38Y [92] CVCL_0379 （页面存档备份，存于互联网档案馆）
LAMA-84 女 29Y [93] CVCL_0388 （页面存档备份，存于互联网档案馆）
MOLM-20 女 63Y [86] CVCL_2121 （页面存档备份，存于互联网档案馆）

CML lymphoid BC

编辑
细胞系 性别 年龄 文献 外部链接
BV-173 男 45Y [94] CVCL_0181 （页面存档备份，存于互联网档案馆）
CML-T1 女 36Y [95] CVCL_1126 （页面存档备份，存于互联网档案馆）
NALM-1 女 3Y [96] CVCL_0091[失效链接]
TK-6 男 30Y [97] CVCL_X907 （页面存档备份，存于互联网档案馆）

骨髓增殖性肿瘤

编辑
细胞系 性别 年龄 文献 外部链接
SET-2 女 71Y [98] CVCL_2187 （页面存档备份，存于互联网档案馆）

另见

编辑

参考文献

编辑
  1. ^ Quentmeier, H; Pommerenke, C; Dirks, WG; Eberth, S; Koeppel, M; MacLeod, RAF; Nagel, S; Steube, K; Uphoff, CC; Drexler, HG. The LL-100 panel: 100 cell lines for blood cancer studies.. Scientific Reports. 3 June 2019, 9 (1): 8218. Bibcode:2019NatSR...9.8218Q. PMC 6547646  . PMID 31160637. doi:10.1038/s41598-019-44491-x. 
  2. ^ Drexler, HG; Quentmeier, H. The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research.. International Journal of Molecular Sciences. 13 August 2020, 21 (16): 5800. PMC 7461097  . PMID 32823535. doi:10.3390/ijms21165800  . 
  3. ^ Findley HW, Jr; Cooper, MD; Kim, TH; Alvarado, C; Ragab, AH. Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes.. Blood. December 1982, 60 (6): 1305–9. PMID 6982733. doi:10.1182/blood.V60.6.1305.1305  . 
  4. ^ Uphoff, CC; MacLeod, RA; Denkmann, SA; Golub, TR; Borkhardt, A; Janssen, JW; Drexler, HG. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.. Leukemia. March 1997, 11 (3): 441–7. PMID 9067587. S2CID 37823510. doi:10.1038/sj.leu.2400571. 
  5. ^ Hurwitz, R; Hozier, J; LeBien, T; Minowada, J; Gajl-Peczalska, K; Kubonishi, I; Kersey, J. Characterization of a leukemic cell line of the pre-B phenotype.. International Journal of Cancer. February 1979, 23 (2): 174–80. PMID 83966. S2CID 29853203. doi:10.1002/ijc.2910230206. 
  6. ^ Rosenfeld, C; Goutner, A; Venuat, AM; Choquet, C; Pico, JL; Dore, JF; Liabeuf, A; Durandy, A; Desgrange, C; De The, G. An effect human leukaemic cell line: Reh.. European Journal of Cancer. April 1977, 13 (4–5): 377–9. PMID 194778. doi:10.1016/0014-2964(77)90085-8. 
  7. ^ Greil, J; Gramatzki, M; Burger, R; Marschalek, R; Peltner, M; Trautmann, U; Hansen-Hagge, TE; Bartram, CR; Fey, GH; Stehr, K. The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7.. British Journal of Haematology. February 1994, 86 (2): 275–83. PMID 8199015. S2CID 44321104. doi:10.1111/j.1365-2141.1994.tb04726.x. 
  8. ^ Menezes, J; Leibold, W; Klein, G; Clements, G. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.. Biomédicine. July 1975, 22 (4): 276–84. PMID 179629. 
  9. ^ Nadkarni, JS; Nadkarni, JJ; Clifford, P; Manolov, G; Fenyö, EM; Klein, E. Characteristics of new cell lines derived from Burkitt lymphomas.. Cancer. January 1969, 23 (1): 64–79. PMID 4178827. S2CID 46405882. doi:10.1002/1097-0142(196901)23:1<64::aid-cncr2820230107>3.0.co;2-m  . 
  10. ^ PULVERTAFT, JV. Cytology of Burkitt's Tumour (African Lymphoma). Lancet. 1 February 1964, 1 (7327): 238–40. PMID 14086209. doi:10.1016/s0140-6736(64)92345-1. 
  11. ^ Klein, G; Giovanella, B; Westman, A; Stehlin, JS; Mumford, D. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.. Intervirology. 1975, 5 (6): 319–34. PMID 181343. doi:10.1159/000149930. 
  12. ^ Kerckaert, JP; Deweindt, C; Tilly, H; Quief, S; Lecocq, G; Bastard, C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas.. Nature Genetics. September 1993, 5 (1): 66–70. PMID 8220427. S2CID 12575122. doi:10.1038/ng0993-66. 
  13. ^ Rosén, A; Bergh, AC; Gogok, P; Evaldsson, C; Myhrinder, AL; Hellqvist, E; Rasul, A; Björkholm, M; Jansson, M; Mansouri, L; Liu, A; Teh, BT; Rosenquist, R; Klein, E. Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.. Oncoimmunology. 1 January 2012, 1 (1): 18–27. PMC 3376971  . PMID 22720208. doi:10.4161/onci.1.1.18400. 
  14. ^ 14.0 14.1 Melo, JV; Brito-Babapulle, V; Foroni, L; Robinson, DS; Luzzatto, L; Catovsky, D. Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement.. International Journal of Cancer. 15 October 1986, 38 (4): 531–8. PMID 3093393. S2CID 10813284. doi:10.1002/ijc.2910380413. 
  15. ^ Melo, JV; Foroni, L; Brito-Babapulle, V; Luzzatto, L; Catovsky, D. The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement.. Clinical and Experimental Immunology. July 1988, 73 (1): 23–8. PMC 1541467  . PMID 3262465. 
  16. ^ Stacchini, A; Aragno, M; Vallario, A; Alfarano, A; Circosta, P; Gottardi, D; Faldella, A; Rege-Cambrin, G; Thunberg, U; Nilsson, K; Caligaris-Cappio, F. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation.. Leukemia Research. February 1999, 23 (2): 127–36. PMID 10071128. doi:10.1016/s0145-2126(98)00154-4. 
  17. ^ Lewin, N; Aman, P; Mellstedt, H; Zech, L; Klein, G. Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines.. International Journal of Cancer. 15 June 1988, 41 (6): 892–5. PMID 2836321. S2CID 38575113. doi:10.1002/ijc.2910410621. 
  18. ^ Epstein, AL; Variakojis, D; Berger, C; Hecht, BK. Use of novel chemical supplements in the establishment of three human malignant lymphoma cell lines (NU-DHL-1, NU-DUL-1, and NU-AMB-1) with chromosome 14 translocations.. International Journal of Cancer. 15 May 1985, 35 (5): 619–27. PMID 2581902. S2CID 38530935. doi:10.1002/ijc.2910350509. 
  19. ^ 19.0 19.1 Tweeddale, ME; Lim, B; Jamal, N; Robinson, J; Zalcberg, J; Lockwood, G; Minden, MD; Messner, HA. The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor.. Blood. May 1987, 69 (5): 1307–14. PMID 3567358. doi:10.1182/blood.V69.5.1307.1307  . 
  20. ^ Th'ng, KH; Garewal, G; Kearney, L; Rassool, F; Melo, JV; White, H; Catovsky, D; Foroni, L; Luzzatto, L; Goldman, JM. Establishment and characterization of three new malignant lymphoid cell lines.. International Journal of Cancer. 15 January 1987, 39 (1): 89–93. PMID 3098690. S2CID 23849509. doi:10.1002/ijc.2910390116. 
  21. ^ Amini, RM; Berglund, M; Rosenquist, R; Von Heideman, A; Lagercrantz, S; Thunberg, U; Bergh, J; Sundström, C; Glimelius, B; Enblad, G. A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma.. Leukemia & Lymphoma. November 2002, 43 (11): 2179–89. PMID 12533045. S2CID 23476994. doi:10.1080/1042819021000032917. 
  22. ^ Fridberg, M; Servin, A; Anagnostaki, L; Linderoth, J; Berglund, M; Söderberg, O; Enblad, G; Rosén, A; Mustelin, T; Jerkeman, M; Persson, JL; Wingren, AG. Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.. Leukemia & Lymphoma. November 2007, 48 (11): 2221–32 [2024-02-02]. PMID 17926183. S2CID 17523509. doi:10.1080/10428190701636443. （原始内容存档于2024-02-05）. 
  23. ^ Kluin-Nelemans, HC; Limpens, J; Meerabux, J; Beverstock, GC; Jansen, JH; de Jong, D; Kluin, PM. A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21).. Leukemia. March 1991, 5 (3): 221–4. PMID 1849602. 
  24. ^ Chang, H; Blondal, JA; Benchimol, S; Minden, MD; Messner, HA. p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.. Leukemia & Lymphoma. September 1995, 19 (1–2): 165–71. PMID 8574164. doi:10.3109/10428199509059672. 
  25. ^ 25.0 25.1 Epstein, AL; Herman, MM; Kim, H; Dorfman, RF; Kaplan, HS. Biology of the human malignant lymphomas. III. Intracranial heterotransplantation in the nude, athymic mouse.. Cancer. May 1976, 37 (5): 2158–76. PMID 177185. S2CID 6013844. doi:10.1002/1097-0142(197605)37:5<2158::aid-cncr2820370503>3.0.co;2-f. 
  26. ^ Al-Katib, AM; Smith, MR; Kamanda, WS; Pettit, GR; Hamdan, M; Mohamed, AN; Chelladurai, B; Mohammad, RM. Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts.. Clinical Cancer Research. May 1998, 4 (5): 1305–14. PMID 9607591. 
  27. ^ Wientjens, GJ; Jansen, JH; Wessels, HW; Kibbelaar, RE; Beverstock, GC; Brederoo, P; Kluin-Nelemans, HC. Characterization of a New Human B Cell Line (Bonna-12) with Trisomy 9 and Trisomy 12 Chromosomal Abnormality.. Leukemia & Lymphoma. 1991, 5 (5–6): 415–22. PMID 27463354. doi:10.3109/10428199109067637. 
  28. ^ Matsuo, Y; Sagawa, K; Yokoyama, M; Koga, T; Yamaguchi, T; Morita, M; Minowada, J. [Establishment and characterization of hairy cell leukemia cell line (Hair-M)].. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society. November 1983, 46 (6): 1222–32. PMID 6608852. 
  29. ^ Schiller, JH; Bittner, G; Meisner, LF; Oberley, TD; Norback, D; Schwabe, M; Faltynek, CR; Raab-Traub, N. Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient.. Leukemia. May 1991, 5 (5): 399–407. PMID 1851909. 
  30. ^ Lukas, J; Jadayel, D; Bartkova, J; Nacheva, E; Dyer, MJ; Strauss, M; Bartek, J. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.. Oncogene. August 1994, 9 (8): 2159–67. PMID 8036001. 
  31. ^ Jeon, HJ; Kim, CW; Yoshino, T; Akagi, T. Establishment and characterization of a mantle cell lymphoma cell line.. British Journal of Haematology. September 1998, 102 (5): 1323–6. PMID 9753063. S2CID 29818033. doi:10.1046/j.1365-2141.1998.00911.x  . 
  32. ^ Lai, R; McDonnell, TJ; O'Connor, SL; Medeiros, LJ; Oudat, R; Keating, M; Morgan, MB; Curiel, TJ; Ford, RJ. Establishment and characterization of a new mantle cell lymphoma cell line, Mino.. Leukemia Research. September 2002, 26 (9): 849–55. PMID 12127561. doi:10.1016/s0145-2126(02)00013-9. 
  33. ^ Szepetowski, P; Simon, MP; Grosgeorge, J; Huebner, K; Bastard, C; Evans, GA; Tsujimoto, Y; Birnbaum, D; Theillet, C; Gaudray, P. Localization of 11q13 loci with respect to regional chromosomal breakpoints.. Genomics. April 1992, 12 (4): 738–44. PMID 1572647. doi:10.1016/0888-7543(92)90303-a. 
  34. ^ Arvanitakis, L; Mesri, EA; Nador, RG; Said, JW; Asch, AS; Knowles, DM; Cesarman, E. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus.. Blood. 1 October 1996, 88 (7): 2648–54. PMID 8839859. doi:10.1182/blood.V88.7.2648.bloodjournal8872648  . 
  35. ^ Renne, R; Zhong, W; Herndier, B; McGrath, M; Abbey, N; Kedes, D; Ganem, D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.. Nature Medicine. March 1996, 2 (3): 342–6. PMID 8612236. S2CID 20384290. doi:10.1038/nm0396-342. 
  36. ^ Carbone, A; Cilia, AM; Gloghini, A; Canzonieri, V; Pastore, C; Todesco, M; Cozzi, M; Perin, T; Volpe, R; Pinto, A; Gaidano, G. Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions.. International Journal of Cancer. 14 November 1997, 73 (4): 562–9. PMID 9389573. S2CID 32367275. doi:10.1002/(sici)1097-0215(19971114)73:4<562::aid-ijc18>3.0.co;2-b. 
  37. ^ Carbone, A; Cilia, AM; Gloghini, A; Capello, D; Todesco, M; Quattrone, S; Volpe, R; Gaidano, G. Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8.. British Journal of Haematology. September 1998, 102 (4): 1081–9. PMID 9734661. S2CID 23440348. doi:10.1046/j.1365-2141.1998.00877.x  . 
  38. ^ Sambade, C; Berglund, M; Lagercrantz, S; Sällström, J; Reis, RM; Enblad, G; Glimelius, B; Sundström, C. U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.. International Journal of Cancer. 1 February 2006, 118 (3): 555–63. PMID 16106419. S2CID 12837372. doi:10.1002/ijc.21417  . 
  39. ^ Ohtsuki, T; Yawata, Y; Wada, H; Sugihara, T; Mori, M; Namba, M. Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).. British Journal of Haematology. October 1989, 73 (2): 199–204. PMID 2479409. S2CID 29676750. doi:10.1111/j.1365-2141.1989.tb00252.x. 
  40. ^ Diehl, V; Schaadt, M; Kirchner, H; Hellriegel, KP; Gudat, F; Fonatsch, C; Laskewitz, E; Guggenheim, R. Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study.. Blut. 20 June 1978, 36 (6): 331–8. PMID 207377. S2CID 22828123. doi:10.1007/BF01000590. 
  41. ^ Pegoraro, L; Malavasi, F; Bellone, G; Massaia, M; Boccadoro, M; Saglio, G; Guerrasio, A; Benetton, G; Lombardi, L; Coda, R. The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation.. Blood. March 1989, 73 (4): 1020–7. PMID 2784066. doi:10.1182/blood.V73.4.1020.1020  . 
  42. ^ Katagiri, S; Yonezawa, T; Kuyama, J; Kanayama, Y; Nishida, K; Abe, T; Tamaki, T; Ohnishi, M; Tarui, S. Two distinct human myeloma cell lines originating from one patient with myeloma.. International Journal of Cancer. 15 August 1985, 36 (2): 241–6. PMID 3926660. S2CID 20506312. doi:10.1002/ijc.2910360217. 
  43. ^ Matsuoka, Y; Moore, GE; Yagi, Y; Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.. Proceedings of the Society for Experimental Biology and Medicine. August 1967, 125 (4): 1246–50. PMID 6042436. S2CID 9643262. doi:10.3181/00379727-125-32327. 
  44. ^ Nilsson, K; Bennich, H; Johansson, SG; Pontén, J. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.. Clinical and Experimental Immunology. October 1970, 7 (4): 477–89. PMC 1712861  . PMID 4097745. 
  45. ^ 45.0 45.1 Drexler, HG; Gaedicke, G; Lok, MS; Diehl, V; Minowada, J. Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles.. Leukemia Research. 1986, 10 (5): 487–500. PMID 3713248. doi:10.1016/0145-2126(86)90084-6. 
  46. ^ Kamesaki, H; Fukuhara, S; Tatsumi, E; Uchino, H; Yamabe, H; Miwa, H; Shirakawa, S; Hatanaka, M; Honjo, T. Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease.. Blood. July 1986, 68 (1): 285–92. PMID 3013343. doi:10.1182/blood.V68.1.285.285  . 
  47. ^ Wolf, J; Kapp, U; Bohlen, H; Kornacker, M; Schoch, C; Stahl, B; Mücke, S; von Kalle, C; Fonatsch, C; Schaefer, HE; Hansmann, ML; Diehl, V. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells.. Blood. 15 April 1996, 87 (8): 3418–28. PMID 8605360. doi:10.1182/blood.V87.8.3418.bloodjournal8783418  . 
  48. ^ Naumovski, L; Utz, PJ; Bergstrom, SK; Morgan, R; Molina, A; Toole, JJ; Glader, BE; McFall, P; Weiss, LM; Warnke, R. SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma.. Blood. December 1989, 74 (8): 2733–42. PMID 2554995. doi:10.1182/blood.V74.8.2733.2733  . 
  49. ^ FOLEY, GE; LAZARUS, H; FARBER, S; UZMAN, BG; BOONE, BA; MCCARTHY, RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. April 1965, 18 (4): 522–9. PMID 14278051. S2CID 32647486. doi:10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j  . 
  50. ^ Heyman, M; Grandér, D; Bröndum-Nielsen, K; Cederblad, B; Liu, Y; Xu, B; Einhorn, S. Interferon system defects in malignant T-cells.. Leukemia. March 1994, 8 (3): 425–34. PMID 8127147. 
  51. ^ Morikawa, S; Tatsumi, E; Baba, M; Harada, T; Yasuhira, K. Two E-rosette-forming lymphoid cell lines.. International Journal of Cancer. 15 February 1978, 21 (2): 166–70. PMID 203546. S2CID 9032666. doi:10.1002/ijc.2910210207. 
  52. ^ Abraham, RT; Weiss, A. Jurkat T cells and development of the T-cell receptor signalling paradigm.. Nature Reviews. Immunology. April 2004, 4 (4): 301–8. PMID 15057788. S2CID 13253575. doi:10.1038/nri1330. 
  53. ^ Minowada, J; Onuma, T; Moore, GE. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.. Journal of the National Cancer Institute. September 1972, 49 (3): 891–5. PMID 4567231. 
  54. ^ Huang, CC; Hou, Y; Woods, LK; Moore, GE; Minowada, J. Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia.. Journal of the National Cancer Institute. September 1974, 53 (3): 655–60. PMID 4547172. doi:10.1093/jnci/53.3.655. 
  55. ^ Di Noto, R; Pane, F; Camera, A; Luciano, L; Barone, M; Lo Pardo, C; Boccuni, P; Intrieri, M; Izzo, B; Villa, MR; Macrí, M; Rotoli, B; Sacchetti, L; Salvatore, F; Del Vecchio, L. Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma.. Leukemia. October 2001, 15 (10): 1641–9. PMID 11587224. S2CID 25177712. doi:10.1038/sj.leu.2402239. 
  56. ^ Starkebaum, G; Loughran TP, Jr; Waters, CA; Ruscetti, FW. Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor.. International Journal of Cancer. 9 September 1991, 49 (2): 246–53. PMID 1879969. S2CID 8605186. doi:10.1002/ijc.2910490218. 
  57. ^ Matsuo, Y; Drexler, HG; Takeuchi, M; Tanaka, M; Orita, K. Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens.. Leukemia Research. September 2002, 26 (9): 873–9. PMID 12127564. doi:10.1016/s0145-2126(02)00023-1. 
  58. ^ Yagita, M; Huang, CL; Umehara, H; Matsuo, Y; Tabata, R; Miyake, M; Konaka, Y; Takatsuki, K. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.. Leukemia. May 2000, 14 (5): 922–30. PMID 10803526. S2CID 22938275. doi:10.1038/sj.leu.2401769. 
  59. ^ Gong, J., Maki, G., and Klingemann, H-G. (1994). “Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells”. Leukemia; 8: 652-58.
  60. ^ Yodoi, J; Teshigawara, K; Nikaido, T; Fukui, K; Noma, T; Honjo, T; Takigawa, M; Sasaki, M; Minato, N; Tsudo, M. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).. Journal of Immunology. March 1985, 134 (3): 1623–30. PMID 2578514. S2CID 13147698. doi:10.4049/jimmunol.134.3.1623  . 
  61. ^ Barbey, S; Gogusev, J; Mouly, H; Le Pelletier, O; Smith, W; Richard, S; Soulie, J; Nezelof, C. DEL cell line: a "malignant histiocytosis" CD30+ t(5;6)(q35;p21) cell line.. International Journal of Cancer. 15 March 1990, 45 (3): 546–53. PMID 2307542. S2CID 1472373. doi:10.1002/ijc.2910450329. 
  62. ^ Su, IJ; Balk, SP; Kadin, ME. Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies.. The American Journal of Pathology. August 1988, 132 (2): 192–8. PMC 1880737  . PMID 2456698. 
  63. ^ Epstein, AL; Kaplan, HS. Biology of the human malignant lymphomas. I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas.. Cancer. December 1974, 34 (6): 1851–72. PMID 4140017. S2CID 27701046. doi:10.1002/1097-0142(197412)34:6<1851::aid-cncr2820340602>3.0.co;2-4  . 
  64. ^ Morgan, R; Smith, SD; Hecht, BK; Christy, V; Mellentin, JD; Warnke, R; Cleary, ML. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis.. Blood. June 1989, 73 (8): 2155–64. PMID 2525056. doi:10.1182/blood.V73.8.2155.2155  . 
  65. ^ Mayumi, M. EoL-1, a human eosinophilic cell line.. Leukemia & Lymphoma. June 1992, 7 (3): 243–50 [2019-12-23]. PMID 1477652. doi:10.3109/10428199209053629. （原始内容存档于2019-12-23）. 
  66. ^ Gallagher, R; Collins, S; Trujillo, J; McCredie, K; Ahearn, M; Tsai, S; Metzgar, R; Aulakh, G; Ting, R; Ruscetti, F; Gallo, R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.. Blood. September 1979, 54 (3): 713–33. PMID 288488. doi:10.1182/blood.V54.3.713.713  . 
  67. ^ Asou, H; Tashiro, S; Hamamoto, K; Otsuji, A; Kita, K; Kamada, N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.. Blood. 1 May 1991, 77 (9): 2031–6. PMID 2018839. doi:10.1182/blood.V77.9.2031.2031  . 
  68. ^ Mrózek, K; Tanner, SM; Heinonen, K; Bloomfield, CD. Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization.. Genes, Chromosomes & Cancer. November 2003, 38 (3): 249–52. PMID 14506699. S2CID 6018408. doi:10.1002/gcc.10274  . 
  69. ^ Lanotte, M; Martin-Thouvenin, V; Najman, S; Balerini, P; Valensi, F; Berger, R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).. Blood. 1 March 1991, 77 (5): 1080–6. PMID 1995093. doi:10.1182/blood.V77.5.1080.1080  . 
  70. ^ Wang, C; Curtis, JE; Minden, MD; McCulloch, EA. Expression of a retinoic acid receptor gene in myeloid leukemia cells.. Leukemia. April 1989, 3 (4): 264–9. PMID 2538684. 
  71. ^ Matozaki, S; Nakagawa, T; Kawaguchi, R; Aozaki, R; Tsutsumi, M; Murayama, T; Koizumi, T; Nishimura, R; Isobe, T; Chihara, K. Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression.. British Journal of Haematology. April 1995, 89 (4): 805–11. PMID 7772516. S2CID 40610063. doi:10.1111/j.1365-2141.1995.tb08418.x. 
  72. ^ Yanagisawa, K; Horiuchi, T; Fujita, S. Establishment and characterization of a new human leukemia cell line derived from M4E0.. Blood. 15 July 1991, 78 (2): 451–7. PMID 2070080. doi:10.1182/blood.V78.2.451.451  . 
  73. ^ Matsuo, Y; MacLeod, RA; Uphoff, CC; Drexler, HG; Nishizaki, C; Katayama, Y; Kimura, G; Fujii, N; Omoto, E; Harada, M; Orita, K. Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23).. Leukemia. September 1997, 11 (9): 1469–77. PMID 9305600. S2CID 205678428. doi:10.1038/sj.leu.2400768. 
  74. ^ Ziegler-Heitbrock, HW; Thiel, E; Fütterer, A; Herzog, V; Wirtz, A; Riethmüller, G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes.. International Journal of Cancer. 15 March 1988, 41 (3): 456–61. PMID 3162233. S2CID 23268646. doi:10.1002/ijc.2910410324. 
  75. ^ Hu, ZB; Ma, W; Zaborski, M; MacLeod, R; Quentmeier, H; Drexler, HG. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.. Leukemia. June 1996, 10 (6): 1025–40. PMID 8667638. 
  76. ^ Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). International Journal of Cancer. August 1980, 26 (2): 171–6. PMID 6970727. S2CID 43603660. doi:10.1002/ijc.2910260208. 
  77. ^ Sundström C. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. May 1976, 17 (5): 565–77. PMID 178611. S2CID 19334036. doi:10.1002/ijc.2910170504. 
  78. ^ Chiba, S; Takaku, F; Tange, T; Shibuya, K; Misawa, C; Sasaki, K; Miyagawa, K; Yazaki, Y; Hirai, H. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin.. Blood. 1 November 1991, 78 (9): 2261–8. PMID 1834251. doi:10.1182/blood.V78.9.2261.2261  . 
  79. ^ Martin, P; Papayannopoulou, T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression.. Science. 1982-06-11, 216 (4551): 1233–5. Bibcode:1982Sci...216.1233M. PMID 6177045. doi:10.1126/science.6177045. 
  80. ^ Papayannopoulou, T; Nakamoto, B; Kurachi, S; Tweeddale, M; Messner, H. Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations.. Blood. September 1988, 72 (3): 1029–38. PMID 3166384. doi:10.1182/blood.V72.3.1029.bloodjournal7231029  . 
  81. ^ Kitamura, T; Tange, T; Terasawa, T; Chiba, S; Kuwaki, T; Miyagawa, K; Piao, YF; Miyazono, K; Urabe, A; Takaku, F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin.. Journal of Cellular Physiology. August 1989, 140 (2): 323–34. PMID 2663885. S2CID 44794601. doi:10.1002/jcp.1041400219. 
  82. ^ Sato, T; Fuse, A; Eguchi, M; Hayashi, Y; Ryo, R; Adachi, M; Kishimoto, Y; Teramura, M; Mizoguchi, H; Shima, Y. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia.. British Journal of Haematology. June 1989, 72 (2): 184–90. PMID 2527057. S2CID 9036646. doi:10.1111/j.1365-2141.1989.tb07681.x. 
  83. ^ 83.0 83.1 Miura, Y; Komatsu, N; Suda, T. Growth and differentiation of two human megakaryoblastic cell lines; CMK and UT-7.. Progress in Clinical and Biological Research. 1990, 356: 259–70. PMID 2217443. 
  84. ^ Mouthon, MA; Freund, M; Titeux, M; Katz, A; Guichard, J; Breton-Gorius, J; Vainchenker, W. Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis.. Blood. 15 August 1994, 84 (4): 1085–97. PMID 7519473. doi:10.1182/blood.V84.4.1085.1085  . 
  85. ^ Avanzi, GC; Brizzi, MF; Giannotti, J; Ciarletta, A; Yang, YC; Pegoraro, L; Clark, SC. M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3.. Journal of Cellular Physiology. December 1990, 145 (3): 458–64. PMID 2273055. S2CID 39079797. doi:10.1002/jcp.1041450310. 
  86. ^ 86.0 86.1 Quentmeier, H; MacLeod, RA; Zaborski, M; Drexler, HG. JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.. Leukemia. March 2006, 20 (3): 471–6. PMID 16408098. S2CID 1907521. doi:10.1038/sj.leu.2404081. 
  87. ^ Takeuchi, S; Sugito, S; Uemura, Y; Miyagi, T; Kubonishi, I; Taguchi, H; Enzan, H; Ohtsuki, Y; Miyoshi, I. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo.. Leukemia. June 1992, 6 (6): 588–94. PMID 1602796. 
  88. ^ Raskind, WH; Disteche, CM; Keating, A; Singer, JW. Correlation between cytogenetic and molecular findings in human chronic myelogenous leukemia lines EM-2 and EM-3.. Cancer Genetics and Cytogenetics. April 1987, 25 (2): 271–84. PMID 3030532. doi:10.1016/0165-4608(87)90188-9. 
  89. ^ Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. March 1975, 45 (3): 321–334. PMID 163658. doi:10.1182/blood.V45.3.321.321  . 
  90. ^ Drexler HG. The Leukemia-Lymphoma Cell Line Factsbook. San Diego: Academic Press. 2000. 
  91. ^ Kubonishi, I; Miyoshi, I. Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis.. International Journal of Cell Cloning. June 1983, 1 (2): 105–17. PMID 6321612. doi:10.1002/stem.5530010205. 
  92. ^ Kishi, K. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors.. Leukemia Research. 1985, 9 (3): 381–90. PMID 3858609. doi:10.1016/0145-2126(85)90060-8. 
  93. ^ Seigneurin, D; Champelovier, P; Mouchiroud, G; Berthier, R; Leroux, D; Prenant, M; McGregor, J; Starck, J; Morle, F; Micouin, C. Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics.. Experimental Hematology. September 1987, 15 (8): 822–32. PMID 3476310. 
  94. ^ Pegoraro, L; Matera, L; Ritz, J; Levis, A; Palumbo, A; Biagini, G. Establishment of a Ph1-positive human cell line (BV173).. Journal of the National Cancer Institute. March 1983, 70 (3): 447–53. PMID 6572735. 
  95. ^ Kuriyama, K; Gale, RP; Tomonaga, M; Ikeda, S; Yao, E; Klisak, I; Whelan, K; Yakir, H; Ichimaru, M; Sparkes, RS. CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia.. Blood. September 1989, 74 (4): 1381–7. PMID 2788468. S2CID 16883925. doi:10.1182/blood.V74.4.1381.1381  . 
  96. ^ Minowada, J; Tsubota, T; Greaves, MF; Walters, TR. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens.. Journal of the National Cancer Institute. July 1977, 59 (1): 83–7. PMID 301573. doi:10.1093/jnci/59.1.83. 
  97. ^ Watanabe, T; Kataoka, T; Mizuta, S; Kobayashi, M; Uchida, T; Imai, K; Wada, H; Kinoshita, T; Murate, T; Mizutani, S. Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein.. Leukemia. November 1995, 9 (11): 1926–34. PMID 7475285. 
  98. ^ Uozumi, K; Otsuka, M; Ohno, N; Moriyama, T; Suzuki, S; Shimotakahara, S; Matsumura, I; Hanada, S; Arima, T. Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles.. Leukemia. January 2000, 14 (1): 142–52. PMID 10637490. S2CID 3258153. doi:10.1038/sj.leu.2401608. 
检索自“https://zh.wikipedia.org/w/index.php?title=LL-100&oldid=82854006”